This study examines prevention and early detection of cervical cancer through self-administration screening of patients in Western Uganda. The cervix is the opening of the uterus or womb, which is the organ that supports babies before they are born. There are simple tests that let doctors know whether or not patients have cells that may become cancer. Some of the tests determine whether patients have an increased risk for cervical disease, but they do not actually confirm that they have it: these are called "screening" tests. This study may help researchers determine how to best deliver cervical cancer prevention services using the HPV test.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of participants who complete screening
Timeframe: 1 day
Proportion of women 25-49 years of age who complete screening
Timeframe: 1 day
Proportion of participants who receive treatment after a positive screening result
Timeframe: 6 months
Proportion of participants with positive, high-risk human papillomavirus (HPV)
Timeframe: 1 day
Proportion of participants with cervical intraepithelial neoplasia (CIN2)+
Timeframe: 1 day